Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Studying Cardiac Cell-Matrix Interactions In Vitro
Published on: March 22, 2024
A Nanoparticle-Based Strategy to Stabilize 5-Azacytidine and Preserve DNA Demethylation Activity in Human Cardiac
Kantaporn Kheawfu1,2, Chuda Chittasupho1,2, Sudarshan Singh1,3
1Department of Pharmaceutical Science, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Nanoparticle encapsulation enhances the stability of 5-Azacytidine (5-Aza), a drug used for epigenetic reprogramming. This formulation preserves 5-Aza
Area of Science:
- Pharmacology
- Biotechnology
- Epigenetics
Background:
- 5-Azacytidine (5-Aza) is a DNA methyltransferase (DNMT) inhibitor with potential in cardiac remodeling via epigenetic reprogramming of human cardiac fibroblasts (HCFs).
- The clinical use of 5-Aza is limited by its rapid hydrolytic degradation.
- Nanoparticle (NP) encapsulation is explored to improve the stability of labile drugs like 5-Aza.
Purpose of the Study:
- To evaluate the physical and chemical stability of free 5-Aza and 5-Aza-loaded lipid nanoparticles (5-Aza-NP).
- To assess the impact of NP encapsulation on the stability and biological activity of 5-Aza.
- To examine the effects of stored 5-Aza and 5-Aza-NP on DNA methylation-related gene expression in HCFs.
Main Methods:
- Lipid nanoparticles (NPs) were formulated using a hyaluronic acid-stabilized lipid system via solvent displacement.
- Physical stability (size, PDI, zeta potential) was monitored over 96 hours at -20 °C, 4 °C, and 30 °C.
- Chemical stability was assessed using HPLC and kinetic modeling. Functional activity was determined by measuring DNMT1, DNMT3A, and DNMT3B gene expression in HCFs post-treatment with stored formulations.
Main Results:
- 5-Aza-NP exhibited physical stability at 4 °C, while aggregation occurred at -20 °C and thermal variability at 30 °C.
- Free 5-Aza degraded rapidly at 30 °C (6.56% remaining at 72h), whereas 5-Aza-NP showed significantly improved stability (11.54% remaining).
- 5-Aza-NP maintained its ability to suppress DNMT1 expression after 96h storage at 4 °C, unlike free 5-Aza, while DNMT3A/B levels remained unaffected.
Conclusions:
- Nanoparticle encapsulation significantly enhances the physicochemical stability of 5-Azacytidine.
- The 5-Aza-NP formulation preserves the drug's DNMT1-inhibitory activity after storage.
- NP-based delivery represents a promising strategy for stabilizing labile epigenetic drugs like 5-Aza for therapeutic applications.
More Related Videos
06:56Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
Published on: October 4, 2024
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Related Concept Videos
DNA Base Pairing
DNA Base Pairing
RNA Stability
Nuclear Stability
To hold positively charged protons together...
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...